Silence Therapeutics (SLN) Depreciation and Depletion (2020 - 2026)
Silence Therapeutics recorded quarterly Depreciation and Depletion of $72000.0 in Q1 2026, down 6.49% quarter-over-quarter from $77000.0 in Q4 2025, and down 1.37% year-over-year from $73000.0 in Q1 2025.
Silence Therapeutics' Depreciation and Depletion history runs 7 years deep, the most recent figure standing at $72000.0 for Q1 2026.
- In Q1 2026, Depreciation and Depletion fell 1.37% year-over-year to $72000.0; the TTM figure through Mar 2026 stood at $311000.0 (down 20.43% YoY), while the FY2025 annual figure was $312000.0, up 4.0% from the prior year.
- Depreciation and Depletion came in at $72000.0 for Q1 2026 at Silence Therapeutics, down from $77000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $165382.9 in Q4 2022 to a low of $40000.0 in Q4 2024.
- A 5-year average of $114958.2 and a median of $138844.3 in 2024 frame the typical range for Depreciation and Depletion.
- Across the five-year window, Depreciation and Depletion slumped 71.22% in 2024 and surged 92.5% in 2025, its largest moves.
- Silence Therapeutics' Depreciation and Depletion stood at $165382.9 in 2022, then declined by 15.95% to $139009.0 in 2023, then plunged by 71.22% to $40000.0 in 2024, then soared by 92.5% to $77000.0 in 2025, then declined by 6.49% to $72000.0 in 2026.
- According to Business Quant data, Depreciation and Depletion over the past three periods registered $72000.0, $77000.0, and $81000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Silence Therapeutics | 924.61 Mn | 854.53 Mn | 411,000.00 | 72,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72,000.00 |
| Mar 31, 2026 | 72,000.00 |
| Dec 31, 2025 | 77,000.00 |
| Dec 31, 2025 | 77,000.00 |
| Sep 30, 2025 | 81,000.00 |
| Sep 30, 2025 | 81,000.00 |
| Jun 30, 2025 | 81,000.00 |
| Jun 30, 2025 | 81,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Sep 30, 2024 | 139,025.12 |
| Sep 30, 2024 | 139,025.12 |
| Jun 30, 2024 | 138,844.28 |
| Jun 30, 2024 | 138,844.28 |
| Mar 31, 2024 | 88,000.00 |
| Mar 31, 2024 | 88,000.00 |
| Dec 31, 2023 | 139,009.01 |
| Dec 31, 2023 | 139,009.01 |
| Sep 30, 2023 | 146,935.44 |
| Sep 30, 2023 | 146,935.44 |
| Jun 30, 2023 | 145,158.13 |
| Jun 30, 2023 | 145,158.13 |
| Mar 31, 2023 | 143,430.12 |
| Mar 31, 2023 | 143,430.12 |
| Dec 31, 2022 | 165,382.89 |
| Dec 31, 2022 | 165,382.89 |
| Sep 30, 2022 | 133,175.96 |
| Sep 30, 2022 | 133,175.96 |
| Jun 30, 2022 | 141,043.19 |
| Jun 30, 2022 | 141,043.19 |
| Mar 31, 2022 | 150,285.60 |
| Mar 31, 2022 | 150,285.60 |
| Dec 31, 2021 | 86,272.68 |
| Dec 31, 2021 | 86,272.68 |
| Sep 30, 2021 | 146,129.84 |
| Sep 30, 2021 | 146,129.84 |
| Jun 30, 2021 | 164,931.93 |
| Jun 30, 2021 | 164,931.93 |
| Mar 31, 2021 | 169,607.26 |
| Mar 31, 2021 | 169,607.26 |
| Dec 31, 2020 | 239,001.63 |
| Dec 31, 2020 | 239,001.63 |
| Sep 30, 2020 | 117,435.75 |
| Sep 30, 2020 | 117,435.75 |